Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4758767
Max Phase: Preclinical
Molecular Formula: C46H57N11O10
Molecular Weight: 924.03
Molecule Type: Unknown
Associated Items:
ID: ALA4758767
Max Phase: Preclinical
Molecular Formula: C46H57N11O10
Molecular Weight: 924.03
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(N)=O
Standard InChI: InChI=1S/C46H57N11O10/c47-18-6-5-11-35(43(64)56-36(19-25-12-14-28(58)15-13-25)44(65)53-34(41(50)62)16-17-40(60)61)54-45(66)38(21-27-24-52-33-10-4-2-8-30(27)33)57-46(67)37(55-42(63)31(48)22-39(49)59)20-26-23-51-32-9-3-1-7-29(26)32/h1-4,7-10,12-15,23-24,31,34-38,51-52,58H,5-6,11,16-22,47-48H2,(H2,49,59)(H2,50,62)(H,53,65)(H,54,66)(H,55,63)(H,56,64)(H,57,67)(H,60,61)/t31-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: FSIFXQDHUWTUKW-DLXWRWKMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 924.03 | Molecular Weight (Monoisotopic): 923.4290 | AlogP: -0.51 | #Rotatable Bonds: 26 |
Polar Surface Area: 372.83 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.97 | CX Basic pKa: 10.27 | CX LogP: -3.46 | CX LogD: -3.56 |
Aromatic Rings: 5 | Heavy Atoms: 67 | QED Weighted: 0.03 | Np Likeness Score: 0.23 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):